Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

NCT00975416 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

63

Enrollment

NIH

Sponsor class

Conditions

Drug Dependence

Interventions

BEHAVIORAL: Cognitive Behavioral Therapy
DRUG: Intranasal Oxytocin
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)